Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension

NCT02220634 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped PI left National Jewish Health

Conditions

Pulmonary Hypertension

Interventions

DRUG: Regadenoson

Sponsor

National Jewish Health

Collaborators

[object Object]